Skip to main content

Advertisement

Log in

A Novel Pathogenic Variant in PRF1 Associated with Hemophagocytic Lymphohistiocytosis

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Familial Hemophagocytic Lymphohistiocytosis type 2 (FHL2) results from mutations in PRF1. We described two unrelated individuals who presented with FHL, in whom severely impaired NK cytotoxicity and decrease perforin expression was observed. DNA sequencing of PRF1 demonstrated that both were not only heterozygous for the p.54R > C/91A > V haplotype but also presented with the novel variant p.47G > V at the perforin protein. Perforin mRNA was found to be increased in a individual with that genotype. A carrier of the novel variant also demonstrated altered perforin mRNA and protein expression. Phylogenetic analysis and multiple alignments with perforin orthologous demonstrated a high level of conservation at Gly47. PolyPhen-2 and PROVEAN predicted p.47G > V to be “probably damaging” and “deleterious”, respectively. A thermodynamic analysis showed that this variant was highly stabilizing, decreasing the protein internal energy. The ab initio perforin molecular modeling indicated that Gly47 is buried inside the hydrophobic core of the MACPF domain, which is crucial for the lytic pore formation and protein oligomerization. After the in silico induction of the p.47G > V mutation, Val47 increased the interactions with the surrounding amino acids due to its size and physical properties, avoiding a proper conformational change of the domain. To our knowledge, this is the first description supporting that p.47G > V is a pathogenic variant that in conjunction with p.54R > C/91A > V might result in the clinical phenotype of FHL2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Goransdotter EK, Fadeel B, Nilsson-Ardnor S, Söderhäll C, Samuelsson A, Janka G, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68(3):590–7.

    Article  Google Scholar 

  2. Trizzino A, ZurStadt U, Ueda I, Risma K, Janka G, Ishii E, et al. Genotype–phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations. J Med Genet. 2008;45(1):15–21.

    Article  CAS  PubMed  Google Scholar 

  3. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002;99(1):61–6.

    Article  CAS  PubMed  Google Scholar 

  4. Feldmann J, Le Deist F, Ouachee-Chardin M, Certain S, Alexander S, Quartier P, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002;117(4):965–72.

    Article  CAS  PubMed  Google Scholar 

  5. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233–46.

    Article  CAS  PubMed  Google Scholar 

  6. Voskoboinik I, Smyth MJ, Trapani JA. Perforin- mediated target-cell death and immune homeostasis. Nat Rev Immunol. 2006;6:940–52.

    Article  CAS  PubMed  Google Scholar 

  7. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957–9.

    Article  CAS  PubMed  Google Scholar 

  8. Baran K, Dunstone M, Chia J, et al. The Molecular basis for Perforin Oligomerization and Transmembrane Pore Assembly. Immunity. 2009;30(5):684–95.

    Article  CAS  PubMed  Google Scholar 

  9. Law RH, Lukoyanova N, Voskoboinik I, et al. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature. 2010;468(7322):447–51.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang K, Jordan MB, Marsh RA, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118(22):5794–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Zhang K, Chandrakasan S, Chapman H, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood. 2014;124(8):1331–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Mhatre S, Madkaikar M, Desai M, Ghosh K. Spectrum of perforin gene mutations in familialhemophagocytic lymphohistiocytosis (FHL) patients in India. Blood Cells Mol Dis. 2015;54(3):250-7.

  13. Risma KA, Frayer RW, Filipovich AH, et al. Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest. 2006;116(1):182–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Peitsch MC, Amiguet P, Guy R, Brunner J, Maizel Jr JV, Tschopp J. Localization and molecular modelling of the membrane-inserted domain of the ninth component of human complement and perforin. Mol Immunol. 1990;27(7):589–602.

    Article  CAS  PubMed  Google Scholar 

  15. Sánchez IP, Leal-Esteban LC, Álvarez-Álvarez JA, et al. Analyses of the PRF1 gene in individuals with hemophagocytic lymphohystiocytosis reveal the common haplotype R54C/A91V in Colombian unrelated families associated with late onset disease. J Clin Immunol. 2012;32(4):670–80.

    Article  PubMed  Google Scholar 

  16. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.

    Article  PubMed  Google Scholar 

  17. Li S, Ma D, Zhang L, et al. High levels of FCcR3A and PRF1 expression in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Dig Dis Sci. 2013;58:458–64.

    Article  CAS  PubMed  Google Scholar 

  18. Chia J, Thia K, Brennan AJ, Little M, Williams B, Lopez JA, et al. Fatal immune dysregulation due to a gain of glycosylation mutation in lymphocyte perforin. Blood. 2012;119(7):1713–6.

    Article  CAS  PubMed  Google Scholar 

  19. National Center for Biotechnology Information, PRF1 gene reference sequence information (http://www.ncbi.nlm.nih.gov/gene/5551 )

  20. Hall, T. BioEdit: Biological sequence alignment software. Ibis Biosciences. Version 7.2.3. http://www.mbio.ncsu.edu/BioEdit/bioedit.html

  21. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9. http://genetics.bwh.harvard.edu/pph2/.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid aubstitutions and indels. PLoS ONE. 2012;7(10):e46688. PROVEAN (Protein Variation Effect Analyzer). (http://provean.jcvi.org/seq_submit.php).

  23. Dehouck Y, Kwasigroch JM, Gilis D, Rooman M. PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality. BMC Bioinformatics. 2011;12:151. http://babylone.ulb.ac.be/PoPV2a/index.php.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Worth CL, Preissner R, Blundell TL. SDM--a server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res. 2011;39 (Web Server issue):W215-22. (http://mordred.bioc.cam.ac.uk/sdm/sdm.php)

  25. UniProt Consortium 2013, UniProtKB Protein Knowledgebase. http://www.uniprot.org/

  26. Larkin MA, Blackshields G, Brown NP, et al. ClustalW and ClustalX version 2.0. Bioinformatics. 2007;23(21):2947–8. http://www.clustal.org.

    Article  CAS  PubMed  Google Scholar 

  27. Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–9. http://www.megasoftware.net.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Berman HM, Battistuz T, Bhat TN, et al. The protein data bank. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 6 No 1):899–907. http://www .pdb.org/.

    Article  PubMed  Google Scholar 

  29. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008;9:40. http://zhanglab.ccmb.med.umich.edu/I-TASSER/.

    Article  PubMed Central  PubMed  Google Scholar 

  30. The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC

  31. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera–a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–12. http://www.cgl.ucsf.edu/chimera.

    Article  CAS  PubMed  Google Scholar 

  32. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714–23. http://spdbv.vital-it.ch/.

    Article  CAS  PubMed  Google Scholar 

  33. Julenius K. NetCGlyc 1.0: prediction of mammalian C-mannosylation sites. Glycobiology. 2007;17(8):868–76. http://www.cbs.dtu.dk/services/NetCGlyc/.

    Article  CAS  PubMed  Google Scholar 

  34. Gupta R, Jung E, Brunak S. Prediction of N-glycosylation sites in human proteins. In preparation, 2004. http://www.cbs.dtu.dk/services/NetNGlyc/

  35. Steentoft C, Vakhrushev SY, Joshi HJ, et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J. 2013;32(10):1478–88. http://www.cbs.dtu.dk/services/NetOGlyc/.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: {170280}: {12/06/2013}. http://omim.org/

  37. An O, Gursoy A, Gurgey A, Keskin O. Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocyticlymphohistiocytosis type 2 (FHL2) patients. Protein Sci. 2013;22(6):823–39.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Ramachandran S, Kota P, Ding F, Dokholyan NV. Automated minimization of steric clashes in protein structures. Proteins. 2011;79(1):261–70.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100(6):2266–7.

    Article  CAS  PubMed  Google Scholar 

  40. Ueda I, Kurokawa Y, Koike K, Ito S, Sakata A, Matsumora T, et al. Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol. 2007;82(6):427–32.

    Article  CAS  PubMed  Google Scholar 

  41. Kim N, Kim M, Yun S, et al. MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1. J Allergy Clin Immunol. 2014;134(1):195–203.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Marcenaro S, Gallo F, Martini S, et al. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 2006;108(7):2316–23.

    Article  CAS  PubMed  Google Scholar 

  43. Bryceson YT, Pende D, Maul-Pavicic A, et al. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood. 2012;119(12):2754–63.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to the patients’ families and healthy control volunteers involved in this study for their participation and cooperation. JAP acknowledges the grants from Vicerrectoría de Investigación (CIQF-177) and Estrategia de Sostenibilidad 2013–2014, Universidad de Antioquia. We thank Javier Rendón for his medical advice. This study was supported by the Colombian Institute for the development of Science and Technology, COLCIENCIAS (Grant #111556934426) and Estrategia de Sostenibilidad 2011–2012, Vicerrectoría de Investigaciones-Universidad de Antioquia, Medellin- Colombia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudia Milena Trujillo-Vargas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Romero, C.A.P., Sánchez, I.P., Gutierrez-Hincapié, S. et al. A Novel Pathogenic Variant in PRF1 Associated with Hemophagocytic Lymphohistiocytosis. J Clin Immunol 35, 501–511 (2015). https://doi.org/10.1007/s10875-015-0169-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-015-0169-x

Keywords

Navigation